期刊文献+

冠心病患者颈动脉斑块类型与发生心肌梗塞的关系 被引量:3

Relationship between the atherosclerotic plaque types in the carotid and the myocardial infarction with coronary artery diseases
下载PDF
导出
摘要 目的探讨颈动脉斑块的不同类型与冠心病发生急性心肌梗塞的关系。方法58例临床诊断为冠心病并伴明显临床症状者,用超声检测颈动脉斑块类型、数量、厚度情况,并随访观察4-8个月,分析斑块类型与随访期内发生急性心肌梗塞的关系。结果颈动脉血管超声显示以软斑块及含有软斑块为主的混合性斑块的患者急性心肌梗塞发生率95.3%(41/43)显著高于以硬斑块为主的患者6.7%(1/15),P<0.01。斑块数量及斑块厚度与急性心肌梗塞的发生率无关。相关分析显示,只有斑块类型与急性心肌梗塞的发生相关。结论冠心病患者,超声检测颈动脉斑块性质可能具有预测急性心肌梗塞发生的作用。 Objective To evaluate the relationship between caused coronary artery diseases the types of carotid atherosclerotic plaque and myocardial infrartion. Methods The 58 patients of coronary artery disease diagnosed clinically with symptoms examined with vascular ultrasound to monitor the type, number and thickness of the atherosclerotic plaque of carotid and were followed-up for 4-8 months. The relationship between the differtent type of plaques in carotid the chance of acue myocardial infartion were analyzed. Resluts The patients with soft plaques and mixed plaques had higher rate 95.3%(41/43) of myocardial infartion' s attack than those with hard plaques 6.7%(1/15),(P〈0.01). There was correlation between plaque type and myocardial infarction , and no correlation was found between plaque number or thickness and myocardial infarction. Conclusion carotid ultrasound examnation in patients with coronary artery diseases might play an important role in predicting acute myocardial infartion.
出处 《上海医学影像》 2009年第1期20-21,共2页 Shanghai Medical Imaging
关键词 颈动脉 超声 斑块 冠心病 心肌梗塞 Carotid Ultrasound Plaques Coronary artery disease Myocardial infarction
  • 相关文献

参考文献4

  • 1Allard C,van der wal,Anton E.Becker.Atherosclerotic plaque rupture pathologic basis of plaque stability and instability[J].Cardiovasc Res,1999,41:334-344
  • 2Nagai Y,Matsumoto M,Mettetr EJ.The carotid artery as a noninvasive window for cardiovascular risk in apparently healthy individuals[J].Ultrasound Med Biol,2002,28:1231-1238.
  • 3Salcuni M,Di Lazzaro V,Di Stasi C,et al.The role of Doppler US in the study of carotid system[J].Rays,1995,20:406-425
  • 4张代民,刘志华.他汀类药物在治疗心血管疾病中的多重效应[J].国际心血管病杂志,2008,35(1):42-45. 被引量:20

二级参考文献20

  • 1[1]Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report[J].Circulation,2002,106(25):3143-3142.
  • 2[2]Gotto AM Jr,Whitney E,Stein EA,et al.Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS)[J].Circulation,2000,101(5):477-484.
  • 3[3]Kleemann R,Princen HM,Emeis JJ,et al.Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE-Lei-den transgenic mice:evidence for antiinflammatory effects of rosuvastatin[J].Circulation,2003,108 (11):1368-1374.
  • 4[4]Albert MA,Danielson E,Rifai N,et al.Effect of statin therapy on C-reactive protein levels.,the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study[J].JAMA,2001,286(1):64-70.
  • 5[5]Ridker PM,Cannon CP,Morrow D,et al.C-reactive protein levels and outcomes after statin therapy[J].N Engl J Med,2005,352(1):20-28.
  • 6[6]Nissen SE,Tuzcu EM,Schoenhagen P,et al.Statin therapy,LDL cholesterol,C-reactive protein,and coronary artery disease[J].N Engl J Med,2005,352(1):29-38.
  • 7[7]Ridker PM,JUPITER Study Group.Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity Creactive protein:rationale and design of the JUPITER trial[J].Circulation,2003,108(19):2292-2297.
  • 8[8]von Haehling S,Anker SD,Bassenge E.Statins and the role of nitric oxide in chronic heart failure[J].Heart Fail Rev,2003,8(1):99-106.
  • 9[9]Liao JK.Beyond lipid lowering:the role of statins in vascular protection[J].Int J Cardiol,2002,86(1):5-18.
  • 10[10]Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type Ⅲ nitric oxide synthase in thromhocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449.

共引文献19

同被引文献26

  • 1王文,刘力生.冠心病心肌梗塞大型临床试验方法与进展[J].实用心脑肺血管病杂志,1994,2(1):28-32. 被引量:1
  • 2陈志华,张皓.低密度脂蛋白及其抗体与动脉粥样硬化的关系[J].上海第二医科大学学报,2005,25(6):638-642. 被引量:7
  • 3陈良,张梅,张运,姚桂华.实时三维超声技术在动脉粥样硬化斑块诊断中的应用[J].中国医学影像技术,2005,21(9):1398-1400. 被引量:16
  • 4董振宏,李旭丰.颈动脉粥样硬化与冠心病的临床分析[J].中国心血管病研究,2006,4(6):448-449. 被引量:14
  • 5Pang ZJ.Effect of polysaccharide krestin on the up regulation of macrophage colony-stimulating factor gene expression in protecting mouse peritoneal macrophages from oxidative injury[J].Am J Chin Med,2003,31:11-23.
  • 6Hansson G K.Immune mechanisms in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2001,21(12):1876-1890.
  • 7Atsuhiko Suzue,Masaaki Uno,Keiko T,et al.Comparison between early and late carotid endarterectomy for symptomatic carotid stenosis in relation to oxidized low-density lipoprotein and plaque vulnerability[J].J Vase Surg,2007,46:870-875.
  • 8Gilard M,Arnaud B,Cornily JC,et al.Influence of omeprazole onthe antiplatelet action of clopidogrel associated with aspirin:therandomized,double-blind OCLA(Omeprazole Clopidogrel Aspi-rin)study[J].J Am Coil Cardiol,2008,51(3):256-260.
  • 9Ho PM,Maddox TM,Wang L,et al.Risk of Mverse outcomes associated with concomitant use of elopidogrel and proton pump inhibitors followingacute coronary syndrome[J].JAMA,2009,301(9):937-944.
  • 10Jaurlink DN,Gomes T,Ko DT,et al.A population-based study ofthedrug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180(7):713-718.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部